Brief: TetraLogic announces publication of two papers describing birinapant's preclinical activity in chronic hepatitis B
21/04/2015 13:00
April 21 (Reuters) - TetraLogic Pharmaceuticals Corp TLOG.O : * Announces publication of two papers describing birinapant's preclinical activity in chronic hepatitis B * Source text for Eikon ID:nGNXVDHWEa * Further company coverage TLOG.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Tetralogic Pharmaceuticals
See all newsNewscasts - Grieving father buries son killed by toxic cough syrup in India
Cellect: Soars on merger deal with Quoin Pharmaceuticals
Brief: Tetralogic announces pacts to restructure convertible debt
Brief: Tetralogic Pharmaceuticals says Pete Meyers resigned as CFO
Brief: TetraLogic Pharmaceuticals says birinapant shows no activity in randomized phase 2 mds study